![]() | Only 14 pages are availabe for public view |
Abstract The best management of superficial femoral artery (SFA) occlusive disease is a hot topic. Although, nowadays, we are being presented with a variety of therapeutic options, there is a little level 1 evidence to guide a specific strategy for treatment; moreover we still do not have a definite durable solution for long SFA lesion. In the current study, we compared two modalities of endovascular treatment; DCBs and stents in patients known to have SFA lesions. It is a single centre prospective study that included thirty patients with SFA lesions presented to the cath labs in Ain Shams University and Ain Shams specialized hospitals within the perod from 8/2015 to 6/2016. Statistical analysis showed there was a marked improvement in claudication distance and ABI for both groups of patients at 6 months follow up after intervention that was of no statistically significant difference for both techniques of revascularization. So, endovascular treatment strategy of SFA lesions whether by stenting or DCBs must be meticulously individualized taking into account many factors such as patient’s clinical presentation, vessel characteristics and economics. |